Study of Intravenous Ampion in Adult COVID-19 Patients Requiring Supplemental Oxygen

NCT04839965 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
36
Enrollment
INDUSTRY
Sponsor class

Stopped The AP-017 study was prematurely terminated by the sponsor after an interim analysis.

Conditions

Interventions

Sponsor

Ampio Pharmaceuticals. Inc.